Trial · NCT04457297
Results by group44
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 44
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disease-free Survival 1 (DFS1) | Trifluridine and Tipiracil | 9.30 | 95% Confidence Interval 7.82 to 10.84 | Months | |
| Disease-free Survival 1 (DFS1) | Placebo | 5.55 | 95% Confidence Interval 4.17 to 6.47 | Months | |
| Rate of Conversion to Negative ctDNA | Trifluridine and Tipiracil | 17.2 | 95% Confidence Interval 11.0 to 25.1 | Percentage | |
| Rate of Conversion to Negative ctDNA | Placebo | 12.4 | 95% Confidence Interval 7.1 to 19.6 | Percentage | |
| Disease-free Survival 2 (DFS2) | Trifluridine and Tipiracil | 9.30 | 95% Confidence Interval 7.82 to 10.84 | Months | |
| Disease-free Survival 2 (DFS2) | Placebo | 5.55 | 95% Confidence Interval 4.17 to 6.47 | Months | |
| Overall Survival (OS) | Trifluridine and Tipiracil | NA | 95% Confidence Interval NA to NA | Months | |
| Overall Survival (OS) | Placebo | 37.26 | 95% Confidence Interval NA to NA | Months | |
| Treatment Completion Rate | Trifluridine and Tipiracil | 77.87 | Standard Deviation 30.26 | Percentage of treatment completion | |
| Treatment Completion Rate | Placebo | 78.79 | Standard Deviation 25.46 | Percentage of treatment completion | |
| QOL (Week 24 Only) | Trifluridine and Tipiracil | Global healthstatus/QoL (Week 24) | 0.00 | Standard Deviation 22.71 | scores on a scale |
| QOL (Week 24 Only) | Placebo | Global healthstatus/QoL (Week 24) | 4.36 | Standard Deviation 22.39 | scores on a scale |
| QOL (Week 24 Only) | Trifluridine and Tipiracil | EORTC QLQ-C30 Functional scales: Physical functioning (Week 24) | -1.10 | Standard Deviation 13.64 | scores on a scale |
| QOL (Week 24 Only) | Placebo | EORTC QLQ-C30 Functional scales: Physical functioning (Week 24) | 1.13 | Standard Deviation 9.47 | scores on a scale |
| QOL (Week 24 Only) | Trifluridine and Tipiracil | EORTC QLQ-C30 Functional scales: Role functioning (Week 24) | -3.33 | Standard Deviation 14.27 | scores on a scale |
| QOL (Week 24 Only) | Placebo | EORTC QLQ-C30 Functional scales: Role functioning (Week 24) | -3.33 | Standard Deviation 12.57 | scores on a scale |
| QOL (Week 24 Only) | Trifluridine and Tipiracil | EORTC QLQ-C30 Functional scales: Emotional functioning (Week 24) | 4.22 | Standard Deviation 14.86 | scores on a scale |
| QOL (Week 24 Only) | Placebo | EORTC QLQ-C30 Functional scales: Emotional functioning (Week 24) | 0.64 | Standard Deviation 13.84 | scores on a scale |
| QOL (Week 24 Only) | Trifluridine and Tipiracil | EORTC QLQ-C30 Functional scales: Cognitive functioning (Week 24) | 0.20 | Standard Deviation 15.75 | scores on a scale |
| QOL (Week 24 Only) | Placebo | EORTC QLQ-C30 Functional scales: Cognitive functioning (Week 24) | 2.56 | Standard Deviation 17.49 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04457297/results